Dag Nyholm Selected Research

Dag Nyholm Research Topics

47	Parkinson Disease (Parkinson's Disease) 06/2022 - 03/2002
10	Dyskinesias (Dyskinesia) 01/2021 - 10/2006
3	Infections 01/2021 - 04/2009
2	Parkinsonian Disorders (Parkinsonism) 05/2022 - 01/2017
2	Huntington Disease (Huntington's Disease) 01/2021 - 11/2019
2	Torticollis (Wryneck) 09/2015 - 11/2012
1	Multiple System Atrophy 05/2022
1	Synucleinopathies 05/2022
1	Normal Pressure Hydrocephalus 02/2022
1	Helicobacter Infections 01/2021
1	Psychotic Disorders (Schizoaffective Disorder) 01/2018
1	Movement Disorders (Movement Disorder) 10/2017
1	Hypokinesia (Bradykinesia) 01/2014
1	Inflammation (Inflammations) 04/2009

39	Levodopa (L Dopa)FDA LinkGeneric 06/2022 - 03/2002
25	Carbidopa (Lodosyn)FDA LinkGeneric 06/2022 - 10/2006
4	Pharmaceutical PreparationsIBA 01/2021 - 02/2008
4	Dopamine (Intropin)FDA LinkGeneric 10/2017 - 01/2006
3	levodopa drug combination carbidopa (Nakom)FDA LinkGeneric 01/2016 - 05/2003
2	Biomarkers (Surrogate Marker)IBA 05/2022 - 02/2022
2	N- (3- iodoprop- 2- enyl)- 2- beta- carbomethoxy- 3- (4- methylphenyl)nortropaneIBA 05/2022 - 01/2017
2	entacapone (Comtan)FDA Link 01/2022 - 01/2017
2	SuspensionsIBA 03/2017 - 03/2008
2	abobotulinumtoxinA FDA Link 09/2015 - 11/2012
2	Type A Botulinum Toxins (Botox)FDA Link 09/2015 - 11/2012
2	Botulinum Toxins (Botulinum Toxin)IBA 09/2015 - 11/2012
1	SolutionsIBA 06/2022
1	SynucleinsIBA 05/2022
1	Apomorphine FDA Link 01/2021
1	proenkephalinIBA 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 11/2019
1	Phenylalanine (L-Phenylalanine)FDA Link 11/2019
1	N- (3- fluorophenyl)- 1- ((4- (((3S)- 3- methyl- 1- piperazinyl)methyl)phenyl)acetyl)- 4- piperidinamineIBA 01/2018
1	mesdopetamIBA 01/2018
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2017
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 12/2013
1	Folic Acid (Vitamin M)FDA LinkGeneric 12/2013
1	HomocysteineIBA 12/2013
1	3-methoxytyrosineIBA 04/2013
1	StalevoIBA 02/2011
1	TitaniumIBA 04/2009
1	Dopamine Receptors (Dopamine Receptor)IBA 10/2006
1	Dopamine Agents (Dopaminergic Agents)IBA 01/2006
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2006
1	Carboxy-LyasesIBA 09/2004
1	Drug CombinationsIBA 03/2002

8	Therapeutics 02/2022 - 09/2004
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2006
2	Oral Administration 07/2021 - 03/2019
2	Deep Brain Stimulation 01/2021 - 11/2013
2	Activities of Daily Living (ADL) 09/2015 - 03/2002
1	Intravenous Infusions 06/2022
1	Precision Medicine 07/2021
1	Drug Tapering 01/2017
1	Aftercare (After-Treatment) 09/2015
1	Intramuscular Injections 09/2015
1	Gastrostomy 04/2009
1	Polypharmacy 01/2009